Better outcomes with CFTR-modulators - Stopping symptomatic pulmonary therapies is justified - CON - Adult Cystic Fibrosis Conference, 2023

Therapy and management of CF patients: The changing landscape with CFTR-modulators

Chair(s): Silke Van Koningsbruggen-Rietschel, Nicholas Simmonds

Session type: Pro and con debate

Better outcomes with CFTR-modulators - Stopping symptomatic pulmonary therapies is justified - CON

Dorota Sands

EVENTS HOME

Replay
Slides

Previous presentation

Next presentation

Session content

Better outcomes with CFTR-modulators - Stopping symptomatic pulmonary therapies is justified - PRO

Gwyneth Davies

Replay

Slides

Better outcomes with CFTR-modulators - Stopping symptomatic pulmonary therapies is justified - CON

Dorota Sands

Replay

Slides

PRO/CON Discussion

Gwyneth Davies

Dorota Sands

Replay

What is the future model for CF care? CF care should still take place in CF centres - PRO

Carlo Castellani

Replay

Slides

What is the future model for CF care? CF care should still take place in CF centres - CON (pre-recorded)

Scott Bell

Replay

PRO/CON Discussion

Scott Bell

Carlo Castellani

Replay

Session aims

To understand the changing landscape with CFTR modulators; to gain knowledge about the PROs and CONs for stopping symptomatic pulmonary therapies; to become familiar with potential future models of CF care.

CDN Connection Issue

#{title}